SIGHT SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
SIGHT SCIENCES, INC. (SGHT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 52.59 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-05
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 3.00K shares, a 94.05% decline year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 49.59K shares, a 75.28% decline year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 162.53K shares, a 53.46% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 350.17K shares, a 553.24% increase year-over-year.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 763.75K shares, a 141.64% increase from fiscal 2024.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 316.07K shares, a 61.91% decline from fiscal 2023.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 829.90K shares, a 5.96% decline from fiscal 2022.
- SIGHT SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 882.46K shares, a 486.27% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 3.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 52.59K shares 10-Q · filed 2026-08-05 | 215.13K shares derived: sum of 3 quarters · filed 2026-08-05 | 565.30K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 49.59K shares 10-Q · filed 2026-05-06 | 212.13K shares derived: sum of 2 quarters · filed 2026-05-06 | 562.30K shares derived: sum of 3 quarters · filed 2026-05-06 | 612.72K shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 162.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | 512.70K shares derived: sum of 2 quarters · filed 2026-03-04 | 563.13K shares derived: sum of 3 quarters · filed 2026-03-04 | 763.75K shares 10-K · filed 2026-03-04 |
| 2025-09-30 | 350.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 400.59K shares derived: sum of 2 quarters · filed 2025-11-06 | 601.22K shares 10-Q · filed 2025-11-06 | 707.13K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 50.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 251.05K shares 10-Q · filed 2025-08-07 | 356.96K shares derived: sum of 3 quarters · filed 2025-08-07 | 410.57K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 200.62K shares 10-Q · filed 2025-05-08 | 306.54K shares derived: sum of 2 quarters · filed 2025-05-08 | 360.14K shares derived: sum of 3 quarters · filed 2025-05-08 | 399.97K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 105.92K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | 159.52K shares derived: sum of 2 quarters · filed 2025-03-07 | 199.34K shares derived: sum of 3 quarters · filed 2025-03-07 | 316.07K shares 10-K · filed 2025-03-07 |
| 2024-09-30 | 53.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 93.43K shares derived: sum of 2 quarters · filed 2024-11-07 | 210.16K shares 10-Q · filed 2024-11-07 | 335.43K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 39.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 156.55K shares 10-Q · filed 2024-08-02 | 281.82K shares derived: sum of 3 quarters · filed 2024-08-02 | 395.04K shares derived: sum of 4 quarters · filed 2024-08-02 |
| 2024-03-31 | 116.73K shares 10-Q · filed 2024-05-06 | 242.00K shares derived: sum of 2 quarters · filed 2024-05-06 | 355.21K shares derived: sum of 3 quarters · filed 2024-05-06 | 636.71K shares derived: sum of 4 quarters · filed 2024-05-06 |
| 2023-12-31 | 125.27K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | 238.48K shares derived: sum of 2 quarters · filed 2024-03-13 | 519.98K shares derived: sum of 3 quarters · filed 2024-03-13 | 829.90K shares 10-K · filed 2024-03-13 |
| 2023-09-30 | 113.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 394.72K shares derived: sum of 2 quarters · filed 2023-11-07 | 704.63K shares 10-Q · filed 2023-11-07 | 824.05K shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 281.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 591.42K shares 10-Q · filed 2023-08-07 | 710.83K shares derived: sum of 3 quarters · filed 2023-08-07 | 1.15M shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 309.91K shares 10-Q · filed 2023-05-08 | 429.33K shares derived: sum of 2 quarters · filed 2023-05-08 | 869.58K shares derived: sum of 3 quarters · filed 2023-05-08 | 897.97K shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | 119.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 559.66K shares derived: sum of 2 quarters · filed 2023-03-16 | 588.05K shares derived: sum of 3 quarters · filed 2023-03-16 | 882.46K shares 10-K · filed 2023-03-16 |
| 2022-09-30 | 440.25K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 468.64K shares derived: sum of 2 quarters · filed 2022-11-10 | 763.04K shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 28.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 322.79K shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 294.40K shares 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | 150.52K shares 10-K · filed 2022-03-24 | |||
| 2021-06-30 | 68.19K shares 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |